Joshua Rosen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joshua Rosen
Joshua Rosen is recorded as CEO at Vireo Growth Inc. (VREOF). Vireo Growth Inc. reported in an 8-K filed October 15, 2024 that Joshua Rosen resigned as Interim Chief Financial Officer, effective October 10, 2024. Vireo Growth Inc. reported in an 8-K filed October 15, 2024 that Joshua Rosen resigned as Director, effective October 10, 2024. Vireo Growth Inc. reported in an 8-K filed October 15, 2024 that Joshua Rosen resigned as Chief Executive Officer, effective October 10, 2024. Equibles holds 5 filed executive changes naming Joshua Rosen; each is listed under recent activity with its source filing.
“On October 10, 2024, Joshua Rosen, Chief Executive Officer, Interim Chief Financial Officer and Director of the Company resigned from all of his positions with the Company.”
“On October 10, 2024, Joshua Rosen, Chief Executive Officer, Interim Chief Financial Officer and Director of the Company resigned from all of his positions with the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-02-14–present
-
Vireo Growth Inc. (VREOF)
SEC 8-K
Current2022-12-04–present
-
2023-02-14–2024-10-10
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vireo Growth Inc.
Other people whose current roles at this company are on record from its filings.
- Amber H. Shimpa CEO
- Amber Shimpa CEO
- John Mazarakis CEO, Chairman, Board Member
- Josh Rosen CEO
- Dr. Kyle E. Kingsley Chairman, Board Member
- Joseph Duxbury CFO, Chief Accounting Officer
- Tyson Macdonald CFO
- Sean M. Apfelbaum General Counsel
- Christopher J. Hagedorn Board Member
- John Pennington Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.